← back to search

Cameron J. Herting

Emory University · US
Area of research
Oncology · Genetics
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, and Cancer Research and Treatments.
h-index
15
citations
1,807
works
108
NIH funding
primary concept
email

Recent publications

XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial
OncoImmunology 2025cited by 11position: middledoi
High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma
Cancer Research 2025cited by 2position: middledoi
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine
Cell Reports Medicine 2024cited by 12position: middledoi
A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression
Journal of Clinical Investigation 2023cited by 62position: middledoi
Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly
Science 2023cited by 44position: middledoi
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner
JCI Insight 2023cited by 36position: middledoi
Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer
The Oncologist 2023cited by 32position: middledoi
The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
Cancer and Metastasis Reviews 2021cited by 60position: firstdoi
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
Cancer Immunology Immunotherapy 2021cited by 39position: firstdoi
Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma
Brain 2020cited by 73position: middledoi
Genetic driver mutations introduced in identical cell‐of‐origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade
Glia 2020cited by 44position: middledoi
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response
Science Translational Medicine 2019cited by 290position: middledoi
Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors
OncoImmunology 2019cited by 163position: middledoi
Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma
Nature Communications 2019cited by 110position: middledoi
Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema
Brain 2019cited by 63position: firstdoi
Chromodomain Helicase DNA-Binding Protein 7 Is Suppressed in the Perinecrotic/Ischemic Microenvironment and Is a Novel Regulator of Glioblastoma Angiogenesis
Stem Cells 2019cited by 23position: middledoi
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Cancer Research 2017cited by 674position: middledoi
Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival
Clinical Cancer Research 2017cited by 29position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dolores Hambardzumyan · Cancer Institute (WIA)10 papers (2017–2023)Zhihong Chen · Chinese Academy of Medical Sciences & Peking Union Medical College7 papers (2017–2023)Gregory B. Lesinski · Emory University6 papers (2021–2025)Bassel F. El‐Rayes · University of Alabama at Birmingham5 papers (2021–2025)Frank Szulzewsky · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa5 papers (2019–2023)Jeffrey M. Switchenko · Emory University4 papers (2019–2025)Patrick J. Cimino · Southwestern Medical Center3 papers (2019–2020)James Ross · University of Virginia3 papers (2019–2023)Chrystal M. Paulos · Emory University3 papers (2023–2025)Olatunji B. Alese · Hebron University3 papers (2024–2025)Victor Maximov · Emory University3 papers (2019–2023)Emily R. Greene · Emory University3 papers (2023–2025)Ben Gabanic · Emory University2 papers (2019–2020)Renee Read · Emory University2 papers (2020–2020)Matthew R. Farren · Incyte (United States)2 papers (2021–2023)Natalie K. Horvat · Emory University2 papers (2025–2025)Mohammad Y. Zaidi · Emory University2 papers (2023–2025)Deon B. Doxie · Emory University2 papers (2025–2025)Dmitry M. Shayakhmetov · Emory University2 papers (2019–2023)David H. Gutmann · Lantmännen2 papers (2017–2023)